Shares of PharmaTher Holdings Ltd. (OTC:PHRRF – Get Free Report) shot up 9.7% during trading on Monday . The stock traded as high as $0.55 and last traded at $0.40. 3,910,388 shares traded hands during mid-day trading, an increase of 1,111% from the average session volume of 322,854 shares. The stock had previously closed at $0.36.
PharmaTher Stock Up 9.7%
The business’s 50 day moving average is $0.29 and its 200-day moving average is $0.20.
PharmaTher Company Profile
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury.
Further Reading
- Five stocks we like better than PharmaTher
- What is the Nasdaq? Complete Overview with History
- MNDY Stock Has a Case of the Mondays—Buy Before the Rebound
- What is a support level?
- IPO Market Stays Hot With These 2 Debuting Stocks
- How to Buy Gold Stock and Invest in Gold
- Taiwan Semiconductor Stock: Own It, Don’t Trade It
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
